Brazil suspends drug patent extensions and reschedules key Supreme Court hearing for tomorrow
Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.